SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-014819
Filing Date
2023-03-30
Accepted
2023-03-30 16:12:07
Documents
15
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10050607_8k.htm   iXBRL 8-K 42840
2 EXHIBIT 2.1 brhc10050607_ex2-1.htm EX-2.1 95873
3 EXHIBIT 2.2 brhc10050607_ex2-2.htm EX-2.2 64132
4 EXHIBIT 2.3 brhc10050607_ex2-3.htm EX-2.3 19519
  Complete submission text file 0001140361-23-014819.txt   390155

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbio-20230329.xsd EX-101.SCH 3907
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20230329_lab.xml EX-101.LAB 22546
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20230329_pre.xml EX-101.PRE 16072
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10050607_8k_htm.xml XML 4211
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 23780813
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences